Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China · Delayed Price · Currency is CNY 58.56
+0.23 (0.39%)
Apr 29, 2026, 3:00 PM CST
SHA:688621 Revenue
Beijing Sun-Novo Pharmaceutical Research had revenue of 197.10M CNY in the quarter ending March 31, 2026, a decrease of -14.62%. This brings the company's revenue in the last twelve months to 1.19B, up 12.44% year-over-year. In the year 2025, Beijing Sun-Novo Pharmaceutical Research had annual revenue of 1.22B with 13.33% growth.
Revenue (ttm)
1.19B
Revenue Growth
+12.44%
P/S Ratio
5.38
Revenue / Employee
763.82K
Employees
1,359
Market Cap
6.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.22B | 143.77M | 13.33% |
| Dec 31, 2024 | 1.08B | 146.35M | 15.70% |
| Dec 31, 2023 | 932.12M | 255.51M | 37.76% |
| Dec 31, 2022 | 676.61M | 182.96M | 37.06% |
| Dec 31, 2021 | 493.65M | 146.29M | 42.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition